Titan Q1 FY27 Results Analysis: PAT Surges 63%, Jewellery Drives Growth
CompoundingAI Research
Updated August 07, 2026
2 min read
Positive
Titan Company Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 21,356.00 Cr (+40.40% YoY) and PAT growth of +62.90% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | August 07, 2026 |
|---|
| Quarter | Q1 FY 2026-2027 |
|---|
| Revenue (Q1) | Rs. 21,356.00 Cr (+40.40% YoY) |
|---|
| PAT (Q1) | Rs. 1,777.00 Cr (+62.90% YoY) |
|---|
| EBITDA margin | 13.50% (+246 bps YoY) |
|---|
| EPS (Q1) | Rs. 20.03 (+62.80% YoY) |
|---|
| Market cap | Rs. 439,887.32 Cr |
|---|
| CMP | Rs. 4,941.00 |
|---|
Quarter Snapshot
Titan delivered a strong Q1 with 40.4% revenue growth and 62.9% PAT growth, driven by jewellery and international expansion. Margins expanded meaningfully, though the duty gain inflated reported profitability. Debt buildup and Damas losses remain watch items, but the underlying business shows robust momentum.
Key Investment Insights
Key Positives
- Revenue (excl. bullion) grew 40.4% YoY to Rs.20,753 Cr, with jewellery portfolio up 43%.
- PAT grew 62.9% YoY to Rs.1,777 Cr, EPS at Rs.20.03 (up 62.8%).
- Segment EBIT margin expanded 156 bps YoY to 13.4%; CD-adjusted jewellery EBIT margin improved 67 bps to 10.28%.
- International jewellery revenue scaled 136% YoY to Rs.1,309 Cr.
- Watches EBIT margin of 19.1% remained above the guided mid-teen range.
- All segments (Jewellery, Watches, EyeCare, Others) grew revenue at 21%+ YoY.
Risk Factors
- Debt-equity ratio rose to 1.01x from 0.82x, reflecting higher borrowings for inventory and Damas acquisition.
- Damas remains loss-making (Rs.67 Cr loss in Q1), though revenue is recovering.
- CD-adjusted total-company EBIT margin of 11.4% slightly below Q1FY26's 11.8% due to international drag.
- Revenue growth is materially inflated by gold price inflation (+59% YoY MCX gold) and the one-time duty hike gain of Rs.407 Cr.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now